Clarivate Q4 net loss $863M on $845M impairment; adj EPS $0.23 +4.5%

CLARIVATE PLC

2023-FY EPS reported -$1.47 revenue$2,628,800,000

Q4 revenues $683.7M +1.2% YoY; organic revenue growth 0.1%.
Net loss attributable to ordinary shares $863M due to $844.7M non-cash goodwill impairment; diluted EPS loss $1.30.
Adjusted EBITDA $298.2M (43.6% margin), adj net income $163.4M, adj diluted EPS $0.23 +4.5%.
FY 2023 free cash flow $501.7M +63.7%; total debt reduced $301M to $4,770.3M.
CEO launches multi-year transformation plan to accelerate organic growth; plans to divest non-core assets.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CLARIVATE PLC reported the fourth quarter and year-ended December 31, 2023 results: revenue $683.7 million, net income Net loss attributable to ordinary shares of $863.0 million, EPS Net loss per diluted share of $1.30. Guidance initiated.

Period: the fourth quarter and year-ended December 31, 2023
Revenue: $683.7 million
Net income: Net loss attributable to ordinary shares of $863.0 million
EPS: Net loss per diluted share of $1.30
Guidance: initiated
Result: reported results

Exact text from the filing

of transformative intelligence, today reported results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights • Revenues of $683.7 million increased 1.2%, and decreased 0.6% at constant currency (2) • Organic revenues increased 0.1% as increases in subscription revenues of 2.6% and re-occurring revenues of 3.8% were

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

CLARIVATE PLC filing history →

Source: SEC EDGAR

accession 0001764046-24-000015

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.